Literature DB >> 24731436

Contraceptive use among HIV-positive women in Enugu, southeast Nigeria.

Euzebus C Ezugwu1, Peter O Nkwo2, Polycap U Agu2, Emmanuel O Ugwu2, Augustine O Asogwa2.   

Abstract

OBJECTIVE: To determine the prevalence and pattern of, and factors associated with, contraceptive usage among HIV-positive women in Enugu, southeastern Nigeria.
METHODS: In a questionnaire-based cross-sectional study, 400 consecutive HIV-positive, sexually active women receiving care at the adult HIV clinics of 2 tertiary health institutions in Enugu were interviewed using pre-tested questionnaires between March and August 2012. Descriptive and inferential statistical analysis was carried out via Epi Info.
RESULTS: The rate of contraceptive use was 73.1%; 26.9% (n=91) of women were not using modern contraceptives. Male condoms were the most frequent contraception used (78.1%, n=193), but 48.2% of women reported inconsistent use. The proportion of women using a dual-contraceptive method was 25.1%; none used the female condom. Having a regular sexual partner was significantly associated with use of modern contraception (odds ratio, 73.00; 95% confidence interval, 34.13-156.13; P<0.001). Misconception and fear of adverse effects were the most common reasons for not using contraception.
CONCLUSION: A considerable proportion of HIV-positive women in Enugu who did not desire to achieve pregnancy in the following 2 years (26.9%) had an unmet need for contraception. The use of contraception prevents unintended pregnancy and subsequent mother-to-child transmission of HIV and should be promoted in the region.
Copyright © 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Contraception; Enugu; Family planning; HIV-positive women; Nigeria

Mesh:

Year:  2014        PMID: 24731436     DOI: 10.1016/j.ijgo.2013.12.014

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

1.  Magnitude of dual contraceptive method utilization and the associated factors among women on antiretroviral treatment in Wolaita zone, Southern Ethiopia.

Authors:  Dereje Haile; Berhanu Lagebo
Journal:  Heliyon       Date:  2022-05-31

2.  Factors Associated with Hormonal and Intrauterine Contraceptive Use among HIV-Infected Men and Women in Lilongwe, Malawi: A Cross-Sectional Study.

Authors:  Jennifer H Tang; Sam Phiri; Wingston Ng'ambi; Jamie W Krashin; Linly Mlundira; Thom Chaweza; Bernadette Samala; Hannock Tweya; Mina C Hosseinipour; Lisa B Haddad
Journal:  Infect Dis Obstet Gynecol       Date:  2016-08-24

3.  Systematic review and meta-analysis assessing the knowledge and use of the female condom among Nigerians.

Authors:  Philemon Dauda Shallie; Firoza Haffejee
Journal:  Afr Health Sci       Date:  2021-09       Impact factor: 0.927

4.  Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study.

Authors:  Issifou Yaya; Akouda Akessiwè Patassi; Dadja Essoya Landoh; Essodjèlouna Manani Bignandi; Kanfitine Kolani; Abdel-Daim Daou Namoro; P'Niwè Massoubayo Patchali; Lihanimpo Djalogue; Didier Koumavi Ekouevi; Bayaki Saka
Journal:  BMJ Open       Date:  2018-04-24       Impact factor: 2.692

5.  Perceptions and decision-making with regard to pregnancy among HIV positive women in rural Maputo Province, Mozambique - a qualitative study.

Authors:  Carlos Eduardo Cuinhane; Kristien Roelens; Christophe Vanroelen; Samuel Quive; Gily Coene
Journal:  BMC Womens Health       Date:  2018-10-11       Impact factor: 2.809

6.  Reproductive Plans And Utilization of Contraceptives Among Women Living With HIV.

Authors:  Khadija Kofoworola Adeleye; Margaret Omowaleola Akinwaare; Prisca Olabisi Adejumo
Journal:  Int J MCH AIDS       Date:  2019-11-28

7.  Contraceptive Use and Method Preferences among HIV Positive Women in Ethiopia: A Systematic Review and Meta-analysis.

Authors:  Getnet Gedefaw; Adam Wondmieneh; Asmamaw Demis
Journal:  Biomed Res Int       Date:  2020-09-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.